These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1777652)

  • 1. Apolipoprotein (a) levels in type 1 and type 2 diabetes mellitus.
    Ruotolo G; Zoppo A; Parlavecchia M; Giberti B; Micossi P
    Acta Diabetol; 1991; 28(2):158-61. PubMed ID: 1777652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L; Rossing P; Nielsen FS; Hansen BV; Dyerberg J; Parving HH
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
    Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
    Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients.
    Hirata K; Saku K; Jimi S; Kikuchi S; Hamaguchi H; Arakawa K
    Diabetologia; 1995 Dec; 38(12):1434-42. PubMed ID: 8786017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects.
    Gazzaruso C; Garzaniti A; Falcone C; Geroldi D; Finardi G; Fratino P
    Diabet Med; 2001 Jul; 18(7):589-94. PubMed ID: 11553191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
    Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
    Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised serum apolipoprotein (a) in active diabetic retinopathy.
    Maioli M; Tonolo G; Pacifico A; Ciccarese M; Brizzi P; Kohner EM; Porta M
    Diabetologia; 1993 Jan; 36(1):88-90. PubMed ID: 8436260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size.
    Rainwater DL; MacCluer JW; Stern MP; VandeBerg JL; Haffner SM
    Diabetes; 1994 Jul; 43(7):942-6. PubMed ID: 8013760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
    Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
    Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein (a) levels in patients with type 1 diabetes mellitus are unrelated to metabolic control or vascular disease.
    Knöbl P; Pietschmann P; Schnack C; Prager R; Schernthaner G
    Wien Klin Wochenschr; 1994; 106(23):728-32. PubMed ID: 7856176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein lipids and apolipoproteins (AI, AII, B, CII, CIII) in type 1 and type 2 diabetes mellitus in young Kuwaiti women.
    al-Muhtaseb N; al-Yusef AR; Bajaj JS
    Diabet Med; 1991 Oct; 8(8):732-7. PubMed ID: 1838064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
    O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
    Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus.
    Schernthaner G; Kostner GM; Dieplinger H; Prager R; Mühlhauser I
    Atherosclerosis; 1983 Dec; 49(3):277-93. PubMed ID: 6229255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein A-I, A-II, B, C-II, and C-III in children with insulin-dependent diabetes mellitus.
    al Muhtaseb N; al Yousuf A; Bajaj JS
    Pediatrics; 1992 May; 89(5 Pt 1):936-41. PubMed ID: 1579407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.
    Siegel RD; Cupples A; Schaefer EJ; Wilson PW
    Metabolism; 1996 Oct; 45(10):1267-72. PubMed ID: 8843183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein levels in normolipidemic non-insulin-dependent diabetes mellitus.
    Horng YC; Wei JS; Chang RS; Huang HS; Huang MJ; Huang BY
    J Formos Med Assoc; 1992 Jun; 91(6):590-4. PubMed ID: 1358344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractional esterification rate of HDL particles in patients with type 2 diabetes. Relation to coronary heart disease risk factors.
    Tan MH; Loh KC; Dobiasova M; Frohlich JJ
    Diabetes Care; 1998 Jan; 21(1):139-42. PubMed ID: 9538985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications.
    Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
    Acta Cardiol; 1999 Aug; 54(4):203-7. PubMed ID: 10511896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria.
    Jenkins AJ; Steele JS; Janus ED; Best JD
    Diabetes; 1991 Jun; 40(6):787-90. PubMed ID: 2040396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.